| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,477 |
5,859 |
$174K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,864 |
1,746 |
$61K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,044 |
221 |
$36K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
587 |
214 |
$29K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
452 |
409 |
$20K |
| 99051 |
|
5,530 |
5,140 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,290 |
1,241 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,048 |
503 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
199 |
174 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
63 |
61 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
21 |
19 |
$664.09 |
| 99050 |
|
72 |
66 |
$435.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
46 |
41 |
$286.08 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
344 |
303 |
$230.45 |
| 87807 |
|
29 |
29 |
$112.68 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
16 |
12 |
$15.36 |
| 81002 |
|
12 |
12 |
$0.00 |